Overview
Jessica Hals is an Oncologist and a Hematologist Oncology provider in Weatherford, Texas. Dr. Hals is rated as an Experienced provider by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. Her top areas of expertise are Pleuropulmonary Blastoma, Colorectal Cancer, Familial Colorectal Cancer, and Iron Deficiency Anemia. Dr. Hals is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
920 Santa Fe Dr, Weatherford, TX 76086
Mary Milam is a Hematologist Oncology specialist and an Oncologist in Fort Worth, Texas. Dr. Milam is rated as an Advanced provider by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. Her top areas of expertise are Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Bone Marrow Aspiration, and Ureteroscopy. Dr. Milam is currently accepting new patients.
Oncology-Hematology Consultants PA
Nicole Bartosh is an Oncologist and a Hematologist Oncology provider in Weatherford, Texas. Dr. Bartosh is rated as a Distinguished provider by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. Her top areas of expertise are Paget Disease of the Breast, Non-Hodgkin Lymphoma, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Bartosh is currently accepting new patients.
Texas Oncology PA
Asad Dean is a Hematologist Oncology specialist and an Oncologist in Fort Worth, Texas. Dr. Dean is rated as an Advanced provider by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. His top areas of expertise are Nasopharyngeal Carcinoma, Agranulocytosis, Cor Pulmonale, and Febrile Neutropenia. Dr. Dean is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pleuropulmonary BlastomaDr. Hals isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Hals isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Hals isAdvanced. Learn about Agranulocytosis.
- Antiphospholipid SyndromeDr. Hals isAdvanced. Learn about Antiphospholipid Syndrome.
- Breast CancerDr. Hals isAdvanced. Learn about Breast Cancer.
- Childhood Acute Myeloid Leukemia
- Childhood Iron Deficiency Anemia
- Experienced
- Abdominal Cystic LymphangiomaDr. Hals isExperienced. Learn about Abdominal Cystic Lymphangioma.
- Acute Mountain SicknessDr. Hals isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hals isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Hals isExperienced. Learn about Acute Promyelocytic Leukemia.